NO20072666L - Krystallinske former av en faktor Xa-inhibitor - Google Patents

Krystallinske former av en faktor Xa-inhibitor

Info

Publication number
NO20072666L
NO20072666L NO20072666A NO20072666A NO20072666L NO 20072666 L NO20072666 L NO 20072666L NO 20072666 A NO20072666 A NO 20072666A NO 20072666 A NO20072666 A NO 20072666A NO 20072666 L NO20072666 L NO 20072666L
Authority
NO
Norway
Prior art keywords
crystal forms
inhibitor
factor
crystalline forms
pyridin
Prior art date
Application number
NO20072666A
Other languages
English (en)
Inventor
Mary F Malley
Michael J Orwat
Roxana F Schlam
Steven R Fabian
Bing-Shiou Yang
Victor W Rosso
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20072666L publication Critical patent/NO20072666L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer krystallformer av 3-(1-hydroksy-1-metyl-etyl)-1-(4-metoksyfenyl)-6-[4-(2-okso-2H-pyridin-1-yl)-fenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-on og solvater derav; fremgangsmåter for fremstilling av slike krystallformer; farmasøytiske preparater som omfatter slike krystallformer; og metoder for behandling av tromboemboliske lidelser med slike krystallformer eller slike farmasøytiske preparater.
NO20072666A 2004-12-15 2007-05-25 Krystallinske former av en faktor Xa-inhibitor NO20072666L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63638704P 2004-12-15 2004-12-15
US73798505P 2005-11-18 2005-11-18
PCT/US2005/045158 WO2006065853A2 (en) 2004-12-15 2005-12-14 Crystalline forms of a factor xa inhibitor

Publications (1)

Publication Number Publication Date
NO20072666L true NO20072666L (no) 2007-09-07

Family

ID=36384503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072666A NO20072666L (no) 2004-12-15 2007-05-25 Krystallinske former av en faktor Xa-inhibitor

Country Status (15)

Country Link
US (2) US7371864B2 (no)
EP (1) EP1828187A2 (no)
JP (1) JP2008524228A (no)
KR (1) KR20070087606A (no)
AR (1) AR053990A1 (no)
AU (1) AU2005317158A1 (no)
BR (1) BRPI0519331A2 (no)
CA (1) CA2589886A1 (no)
IL (1) IL183825A0 (no)
MX (1) MX2007006919A (no)
NO (1) NO20072666L (no)
PE (1) PE20060739A1 (no)
RU (1) RU2007126770A (no)
TW (1) TW200634011A (no)
WO (1) WO2006065853A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2610588T3 (es) 2008-05-27 2017-04-28 Dako Denmark A/S Composiciones y métodos para la detección de aberraciones cromosómicas con tampones de hibridación novedosos
WO2010097655A1 (en) * 2009-02-26 2010-09-02 Dako Denmark A/S Compositions and methods for rna hybridization applications
EP2761028A1 (en) 2011-09-30 2014-08-06 Dako Denmark A/S Hybridization compositions and methods using formamide
EP2768974B1 (en) 2011-10-21 2017-07-19 Dako Denmark A/S Hybridization compositions and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320039B (en) * 2001-09-21 2010-02-01 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
BRPI0212726B8 (pt) * 2001-09-21 2021-05-25 Bristol Myers Squibb Co compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US20060069260A1 (en) * 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones

Also Published As

Publication number Publication date
WO2006065853A3 (en) 2006-08-24
US7371864B2 (en) 2008-05-13
IL183825A0 (en) 2007-09-20
US20080188517A1 (en) 2008-08-07
MX2007006919A (es) 2007-06-26
AR053990A1 (es) 2007-05-30
EP1828187A2 (en) 2007-09-05
AU2005317158A1 (en) 2006-06-22
BRPI0519331A2 (pt) 2009-01-20
CA2589886A1 (en) 2006-06-22
JP2008524228A (ja) 2008-07-10
RU2007126770A (ru) 2009-01-27
TW200634011A (en) 2006-10-01
US20060148846A1 (en) 2006-07-06
KR20070087606A (ko) 2007-08-28
PE20060739A1 (es) 2006-08-16
WO2006065853A2 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20066055L (no) Pyridinderivater
ZA200306419B (en) Phenyl derivatives.
NO20071702L (no) Fremgangsmate for fremstilling av 4,5-dihydro-pyrazolo[3,4-C]pyrid-oner
NO20062561L (no) Kinoliner nyttige for behandling av kardiovaskulaere sykdommer
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
NO20073366L (no) 1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20043531L (no) Indazolforbindelser som er nyttige som proteinkinaseinhibitorer
WO2006123088A3 (en) 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
WO2006034093A3 (en) 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
WO2006052899A3 (en) Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
WO2008060476A3 (en) Nitrogen-containing heterocyclic compounds and methods of use thereof
NO20083246L (no) Nye benzimidazolderivater som vanilloid-reseptor 1 (VRL) inhibitorer
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20080033L (no) Kinolinderivater som NK3-antagonister
NO20035571L (no) N-formyl hydroksylaminforbindelser som PDF-inhibitorer
NO20072666L (no) Krystallinske former av en faktor Xa-inhibitor
NO20042861L (no) N-(3-butyn-1-yl)-N-hydroksyurea
WO2005065018A3 (en) Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation